DK1311682T3 - Rekombinante konstruktioner af Borrelia burgdorferi - Google Patents

Rekombinante konstruktioner af Borrelia burgdorferi

Info

Publication number
DK1311682T3
DK1311682T3 DK01959607T DK01959607T DK1311682T3 DK 1311682 T3 DK1311682 T3 DK 1311682T3 DK 01959607 T DK01959607 T DK 01959607T DK 01959607 T DK01959607 T DK 01959607T DK 1311682 T3 DK1311682 T3 DK 1311682T3
Authority
DK
Denmark
Prior art keywords
chimeric
borrelia burgdorferi
recombinant constructs
disclosed
proteins
Prior art date
Application number
DK01959607T
Other languages
Danish (da)
English (en)
Inventor
Benjamin J Luft
John J Dunn
Original Assignee
Univ New York State Res Found
Brookhaven Sciences Ass Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found, Brookhaven Sciences Ass Llc filed Critical Univ New York State Res Found
Application granted granted Critical
Publication of DK1311682T3 publication Critical patent/DK1311682T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK01959607T 2000-08-18 2001-08-07 Rekombinante konstruktioner af Borrelia burgdorferi DK1311682T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22648400P 2000-08-18 2000-08-18
US66601700A 2000-09-19 2000-09-19
PCT/US2001/024736 WO2002016422A2 (fr) 2000-08-18 2001-08-07 Constructions recombinantes de borrelia burgdorferi

Publications (1)

Publication Number Publication Date
DK1311682T3 true DK1311682T3 (da) 2008-05-05

Family

ID=26920578

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01959607T DK1311682T3 (da) 2000-08-18 2001-08-07 Rekombinante konstruktioner af Borrelia burgdorferi

Country Status (8)

Country Link
EP (1) EP1311682B1 (fr)
AT (1) ATE380870T1 (fr)
AU (1) AU2001281145A1 (fr)
DE (1) DE60131858T2 (fr)
DK (1) DK1311682T3 (fr)
ES (1) ES2298246T3 (fr)
PT (1) PT1311682E (fr)
WO (1) WO2002016422A2 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7008625B2 (en) 1993-11-01 2006-03-07 Research Foundation Of The State University Of New York Recombinant constructs of Borrelia burgdorferi
US8821893B2 (en) 2004-07-02 2014-09-02 Bio Peptides, Corp. Oral vaccine for Borrelia
AU2007295927A1 (en) 2006-09-15 2008-03-20 Intercell Ag Borrelia antigens
CA2668100C (fr) * 2006-11-01 2014-12-23 Immport Therapeutics, Inc. Composition et procedes pour des antigenes immunodominants
WO2008116468A2 (fr) 2007-03-26 2008-10-02 Dako Denmark A/S Complexes peptidiques du cmh et leurs utilisations dans des maladies infectieuses
EP2167537A2 (fr) 2007-07-03 2010-03-31 Dako Denmark A/S Procedes compiles pour analyser et trier des echantillons
US10611818B2 (en) 2007-09-27 2020-04-07 Agilent Technologies, Inc. MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
DK2254592T3 (da) 2008-02-28 2019-09-09 Dako Denmark As MHC-multimerer til Borrelia-diagnostik og sygdom
US10722562B2 (en) 2008-07-23 2020-07-28 Immudex Aps Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
WO2010037402A1 (fr) 2008-10-02 2010-04-08 Dako Denmark A/S Vaccins moléculaires contre les maladies infectieuses
WO2011081598A1 (fr) * 2009-12-28 2011-07-07 Mivac Development Aktiebolag Nouveaux antigènes pour une utilisation dans un vaccin contre une infection par h. pylori
JP6227407B2 (ja) * 2010-05-14 2017-11-08 バクスアルタ インコーポレイテッド Ｏｓｐａキメラおよびそのワクチンでの使用法
CA2879689A1 (fr) 2012-07-27 2014-01-30 Baxter International Inc. Compositions comprenant des molecules ospa chimeriques et leurs procedes d'utilisation
PL223175B1 (pl) 2012-10-22 2016-10-31 Inst Chemii Bioorganicznej Polskiej Akademii Nauk Szczepionka przeciw boreliozie, konstrukt genetyczny, rekombinowane białko, sposób otrzymywania konstruktu genetycznego, sposób otrzymywania szczepionki, sposób otrzymywania rekombinowanych białek, zastosowanie rekombinowanych białek do wytwarzania szczepionki przeciwko boreliozie
CZ2014320A3 (cs) * 2014-05-09 2015-11-18 VÝZKUMNÝ ÚSTAV VETERINÁRNÍHO LÉKAŘSTVÍ, v.v.i. Polyepitopový antigen, vakcinační konstrukt a vakcína pro prevenci lymeské boreliózy
JP2017531657A (ja) * 2014-10-07 2017-10-26 ザ リサーチ ファンデーション フォー ザ ステート ユニバーシティ オブ ニューヨーク 組換えボレリアタンパク質およびその使用のための方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2175567C (fr) * 1993-11-01 2010-08-10 John J. Dunn Proteines chimeres comprenant des polypeptides de borrelia et leurs utilisations
DE69938183T2 (de) * 1998-07-31 2009-02-19 Gundersen Lutheran Medical Foundation, Inc., La Crosse Verwendungen eines borreliaziden epitops des aussermembranproteins c von borrelia burgdorferi (ospc) als impstoff

Also Published As

Publication number Publication date
ES2298246T3 (es) 2008-05-16
EP1311682B1 (fr) 2007-12-12
DE60131858D1 (de) 2008-01-24
ATE380870T1 (de) 2007-12-15
DE60131858T2 (de) 2008-12-04
WO2002016422A3 (fr) 2002-10-03
EP1311682A2 (fr) 2003-05-21
WO2002016422A2 (fr) 2002-02-28
PT1311682E (pt) 2008-03-11
AU2001281145A1 (en) 2002-03-04

Similar Documents

Publication Publication Date Title
DK1311682T3 (da) Rekombinante konstruktioner af Borrelia burgdorferi
DK0726955T3 (da) Kimære proteiner, som omfatter Borreliapolypeptider, og anvendelser heraf
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
PL351277A1 (en) Nucleic acid sequence, dna fragments, recombined dna molecules, live recombined carriers, host cells, proteins and their application, vaccines against lawsonia intracellularis and methods of obtaining them as well as relevant diagnostic tests
ATE470673T1 (de) Impfstoffe mit lawsoniaintrazellularis- untereinheit
DK1659179T3 (da) Tumor-associerede antigenderivater fra MAGE-familien og nucleinsyresekvenser kodende for dem anvendt til fremstilling af fusionsproteiner og sammensætninger til vaccination
NO20054836L (no) Nogo-reseptorbindingsprotein
DK1282702T3 (da) Immunogene polypeptider, som er kodet af KAGE-minigener, og anvendelser deraf
WO2004098526A3 (fr) Vaccin a adn anti-cancer faisant appel a des plasmides codant une sequence-signal, un antigene oncoproteine mutant, et une proteine de choc thermique
DE69931284D1 (de) Menschliches Neurotrimin-Homolog
DK1053329T3 (da) Rekombinant lipideret PsaA-protein, fremgangsmåder til fremstilling og anvendelse
WO2003058248A3 (fr) Diagnostics et vaccins paramycobacteriens
WO2003095480A3 (fr) Vaccin de brachyspira hyodysenteriae
ATE450545T1 (de) Impfstoff mit lawsonia intracellularis- untereinheit
DE60139959D1 (de) Nukleinsäureadjuvantien
WO2004007726A3 (fr) Nouveau vaccin a base de brachyspira hyodysenteriae
DK1078072T3 (da) Nye peptidfragmenter til oprensning af proteiner
WO2005002512A3 (fr) Strategie de vaccination immunotherapeutique
WO2004024769A3 (fr) Vaccin contre l'ostertagia
PT1176192E (pt) Vacina de helicobacter felis
AR030133A1 (es) Anticuerpos anti-tnf, composiciones, metodos y usos